High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 117 (2) , 313-320
- https://doi.org/10.1016/s0022-3476(05)80554-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Pharmacokinetics of ribavirin aerosol in miceAntimicrobial Agents and Chemotherapy, 1988
- Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitroAntimicrobial Agents and Chemotherapy, 1987
- Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infectionsAntimicrobial Agents and Chemotherapy, 1987
- Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected miceAntiviral Research, 1987
- Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosolAntimicrobial Agents and Chemotherapy, 1986
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- In vivo inhibition of respiratory syncytial virus by ribavirinAntimicrobial Agents and Chemotherapy, 1982
- Effects of ribavirin on respiratory syncytial virus in vitroAntimicrobial Agents and Chemotherapy, 1980
- Respiratory syncytial virus infections in infants: Quantitation and duration of sheddingThe Journal of Pediatrics, 1976
- Quantitative Shedding Patterns of Respiratory Syncytial Virus in InfantsThe Journal of Infectious Diseases, 1975